Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

IMPORTANCE: During the initial outbreak of the COVID-19 pandemic, cancer clinical trial participation decreased precipitously. Given the continued pandemic—especially the severe wave of new cases and deaths in winter 2020 to 2021—a vital question is whether trial enrollments have remained low or eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger, Joseph M., Xiao, Hong, LeBlanc, Michael, Hershman, Dawn L., Blanke, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323000/
https://www.ncbi.nlm.nih.gov/pubmed/34323986
http://dx.doi.org/10.1001/jamanetworkopen.2021.18433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323000/
https://www.ncbi.nlm.nih.gov/pubmed/34323986
http://dx.doi.org/10.1001/jamanetworkopen.2021.18433

Ejemplares similares